Literature DB >> 9891559

Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell.

R P Takes1, R J Baatenburg de Jong, E Schuuring, S V Litvinov, J Hermans, J H Van Krieken.   

Abstract

BACKGROUND: In most studies concerning chromosomal changes or protein expression in head and neck squamous cell carcinomas (HNSCC) no distinction is made between the sites within this area. The behaviour of tumors arising in one site or the other, however, differs significantly, suggesting different intrinsic tumor properties. In this study we compared the expression of several proteins (p53, Rb, cyclin D1 myc, bcl-2, EGFR, neu, E-Cadherin, Ep-CAM, Desmoplakin1 and nm23) in the three major sites of HNSCC (larynx, pharynx, and oral cavity).
MATERIALS AND METHODS: Expression of the proteins was studied by immunohistochemistry in 33 laryngeal, 31 pharyngeal and 36 oral carcinomas.
RESULTS: Cyclin D1 had a very high level of expression in the pharynx (p = 0.0004) and EGFR very low in the larynx (p < 0.0001) compared to the other sites. To a lesser degree p53 (p = 0.05), Desmoplakin1 (p = 0.04) and Ep-CAM (p = 0.02) showed statistically nearly significant differences. For the other proteins no statistically significant difference in expression was found.
CONCLUSION: These results show that the expression of a number of proteins is not identical in the three major localizations of HNSCC and indicate the different tumor biology of cancers originating from different sites in the Head and Neck. It is therefore not justified to consider the different localizations as one entity. Moreover, these differences may have clinical and prognostic relevance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9891559

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  19 in total

Review 1.  Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review.

Authors:  L Pignataro; G Sambataro; D Pagani; G Pruneri
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-04       Impact factor: 2.124

Review 2.  Molecular therapy in head and neck oncology.

Authors:  Jacques Bernier; Søren M Bentzen; Jan B Vermorken
Journal:  Nat Rev Clin Oncol       Date:  2009-05       Impact factor: 66.675

3.  Head and neck squamous cell carcinoma in pregnant women.

Authors:  Anna M Eliassen; Samantha J Hauff; Alice L Tang; Dafydd H Thomas; Jonathan B McHugh; Heather M Walline; Jay Stoerker; Jessica H Maxwell; Francis P Worden; Avraham Eisbruch; Michael J Czerwinski; Silvana M Papagerakis; Douglas B Chepeha; Carol R Bradford; David A Hanauer; Thomas E Carey; Mark E Prince
Journal:  Head Neck       Date:  2012-03-16       Impact factor: 3.147

4.  Tissue microarray of head and neck squamous carcinoma: validation of the methodology for the study of cutaneous fatty acid-binding protein, vascular endothelial growth factor, involucrin and Ki-67.

Authors:  Wafaey Gomaa; Youqiang Ke; Hiroshi Fujii; Timothy Helliwell
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

5.  Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening.

Authors:  A K El-Naggar; L Mao; G Staerkel; M M Coombes; S L Tucker; M A Luna; G L Clayman; S Lippman; H Goepfert
Journal:  J Mol Diagn       Date:  2001-11       Impact factor: 5.568

6.  Cannabis smoke can be a major risk factor for early-age laryngeal cancer--a molecular signaling-based approach.

Authors:  Sayantan Bhattacharyya; Syamsundar Mandal; Samir Banerjee; Gautam Kumar Mandal; Anup Kumar Bhowmick; Nabendu Murmu
Journal:  Tumour Biol       Date:  2015-03-04

7.  Use of combination proteomic analysis to demonstrate molecular similarity of head and neck squamous cell carcinoma arising from different subsites.

Authors:  Paul M Weinberger; Mark Merkley; Jeffrey R Lee; Bao-Ling Adam; Christine G Gourin; Robert H Podolsky; Bruce G Haffty; Evangelia Papadavid; Clarence Sasaki; Amanda Psyrri; William S Dynan
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-07

8.  Role of EGFR as a prognostic factor for survival in head and neck cancer: a meta-analysis.

Authors:  Shen Keren; Zhang Shoude; Zhao Lu; Yang Beibei
Journal:  Tumour Biol       Date:  2014-03

9.  Tyrosine kinase receptor expression in thymomas.

Authors:  John D Henley; Oscar W Cummings; Patrick J Loehrer
Journal:  J Cancer Res Clin Oncol       Date:  2004-02-05       Impact factor: 4.553

Review 10.  Molecular biology of head and neck cancer: risks and pathways.

Authors:  Michael E Stadler; Mihir R Patel; Marion E Couch; David Neil Hayes
Journal:  Hematol Oncol Clin North Am       Date:  2008-12       Impact factor: 3.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.